Comments on: Merck Shutdown of Rosetta is Seattle’s Loss, Boston’s Gain As Company Tries to Lure Key Researchers East

By: Mark

Mark — Mon, 09 Mar 2009 13:24:23 +0000

Rosetta Inpharmatics should never have moved from Bothell to Seattle.

Arterio — Sat, 08 Nov 2008 05:50:35 +0000

Just a FYI:
Doug is not the head of the Seattle site.
Stephen Friend was not at the initial announcement on Tuesday evening.